Applicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials

被引：0
|
作者：
Varga, A. [1 ]
Bernard-Tessier, A. [2 ]
Auclin, E. [3 ]
Perez, L. Mezquita [2 ]
Baldini, C. [1 ]
Planchard, D. [2 ]
Marabelle, A. [1 ]
Hollebecque, A. [1 ]
Besse, B. [2 ]
Massard, C. [1 ]
机构：
[1] Gustave Roussy Canc Campus, Drug Dev Dept, Villejuif, France
[2] Gustave Roussy Canc Campus, Dept Canc Med, Villejuif, France
[3] Hop European George Pompidou, Oncol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3O
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors
    Igawa, Yukiko Shimoda
    Yoshida, Tatsuya
    Yoshinami, Yuri
    Hibino, Yukiko
    Arima, Takamichi
    Sato, Jun
    Maruki, Yuta
    Shoji, Hirokazu
    Namikawa, Kenjiro
    Sudo, Kazuki
    Honma, Yoshitaka
    Hashimoto, Hironobu
    Yamazaki, Naoya
    Okusaka, Takuji
    Yonemori, Kan
    Yamamoto, Noboru
    Ohe, Yuichiro
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] CIRCULATING LIPID PROFILE AS A PROGNOSTIC FACTOR IN PATIENTS WITH ADVANCED SOLID TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Pecci, Federica
    Cantini, Luca
    Cognigni, Valeria
    Perrone, Fabiana
    Agostinelli, Veronica
    Mazzaschi, Giulia
    Favari, Elda
    Maffezzoli, Michele
    Cortellini, Alessio
    Rossi, Francesca
    Chiariotti, Rebecca
    Venanzi, Francesco
    Mentrasti, Giulia
    Lo Russo, Giuseppe
    Galli, Giulia
    Proto, Claudia
    Ganzinelli, Monica
    Tronconi, Francesca
    Morgese, Francesca
    Campolucci, Carla
    Moretti, Marco
    Vignini, Arianna
    Bersanelli, Melissa
    Buti, Sebastiano
    Berardi, Rossana
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A99 - A100
  • [23] Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma
    Carril-Ajuria, Lucia
    Lavaud, Pernelle
    Dalban, Cecile
    Negrier, Sylvie
    Gravis, Gwenaelle
    Motzer, Robert J.
    Chevreau, Christine
    Tannir, Nizar M.
    Oudard, Stephane
    McDermott, David F.
    Laguerre, Brigitte
    Hammers, Hans J.
    Barthelemy, Philippe
    Plimack, Elizabeth R.
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Jiang, Ruiyun
    Lee, Chung-Wei
    de Silva, Heshani
    Rini, Brian I.
    Escudier, Bernard
    Albiges, Laurence
    EUROPEAN JOURNAL OF CANCER, 2024, 204
  • [24] The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors
    Zhou, J.
    Donaubauer, A.
    Frey, B.
    Becker, I.
    Rutzner, S.
    Sun, R.
    Ma, H.
    Fietkau, R.
    Deutsch, E.
    Gaipl, U.
    Hecht, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S336 - S336
  • [25] BODY COMPOSITION MAY BE PROGNOSTIC AND PREDICTIVE OF CLINICAL OUTCOMES IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
    Martini, Dylan
    Olsen, T. Anders
    Goyal, Subir
    Liu, Yuan
    Evans, Sean
    Magod, Benjamin
    Brown, Jacqueline
    Yantorni, Lauren
    Russler, Greta
    Caulfield, Sarah
    Goldman, Jamie
    Nazha, Bassel
    Harris, Wayne
    Kucuk, Omer
    Carthon, Bradley
    Master, Viraj
    Bilen, Mehmet
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A26 - A27
  • [26] The lung immune prognostic index (LIPI) as prognostic factor in solid tumours: The experience of a community hospital
    Vitorino, M.
    Tomas, T. C.
    de Almeida, S. B.
    Honorio, M.
    Silva, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S1431 - S1432
  • [27] Association of lung immune prognostic index (LIPI) with survival of first line immune checkpoint inhibitors single agent or in combination with chemotherapy in untreated advanced NSCLC patients
    Blanc-Durand, F.
    Auclin, E.
    Planchard, D.
    Ponce Aix, S.
    Hendriks, L.
    Sullivan, I. G.
    Saravia, D.
    Routy, B.
    Lopez Castro, R.
    Pilotto, S.
    Aboubakar, F.
    Kassouf, E.
    Rodriguez, A.
    Amores Martin, A.
    Bluthgen, M. V.
    Duchemann, B.
    Caramella, C.
    Nadal, E.
    Besse, B.
    Mezquita, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 5 - 5
  • [28] Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
    Hou, Baicun
    Wang, Peng
    Liu, Tingting
    Chen, Shixue
    Li, Tao
    Zhang, Sujie
    Tao, Haitao
    Li, Xiaoyan
    Hu, Yi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (05)
  • [29] Value of the Lung Immune Prognostic Index (LIPI) As a Prognostic Tool for Real-World Patients Treated for Mutation-Positive Metastatic NSCLC
    Gibson, A.
    Elegbede, A.
    Dean, M.
    Tudor, R.
    Box, A.
    Stukalin, I.
    Meyers, D.
    Bebb, D. G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S206 - S206
  • [30] Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors
    Zhang, Lilong
    Ma, Wangbin
    Qiu, Zhendong
    Kuang, Tianrui
    Wang, Kunpeng
    Hu, Baohong
    Wang, Weixing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345